KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Invested Capital (2016 - 2025)

Historic Invested Capital for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $293.6 million.

  • Medpace Holdings' Invested Capital fell 6668.62% to $293.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $293.6 million, marking a year-over-year decrease of 6668.62%. This contributed to the annual value of $825.5 million for FY2024, which is 4769.57% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Invested Capital is $293.6 million, which was down 6668.62% from $172.4 million recorded in Q2 2025.
  • Medpace Holdings' 5-year Invested Capital high stood at $952.9 million for Q4 2021, and its period low was $172.4 million during Q2 2025.
  • Its 5-year average for Invested Capital is $619.2 million, with a median of $593.6 million in 2025.
  • Per our database at Business Quant, Medpace Holdings' Invested Capital soared by 8717.7% in 2024 and then tumbled by 7742.91% in 2025.
  • Quarter analysis of 5 years shows Medpace Holdings' Invested Capital stood at $952.9 million in 2021, then plummeted by 54.21% to $436.4 million in 2022, then grew by 28.09% to $558.9 million in 2023, then surged by 47.7% to $825.5 million in 2024, then tumbled by 64.43% to $293.6 million in 2025.
  • Its Invested Capital stands at $293.6 million for Q3 2025, versus $172.4 million for Q2 2025 and $593.6 million for Q1 2025.